Why Mounjaro May Seem Like It's Not Working the Second Time Around

You restarted at 2.5mg when you left off at 10mg, that gap matters more than most people realise

Picture this: you had your last pen in the fridge door, missed a few weeks due to travel or illness, and then a longer pause turned into months. By the time you restarted, clinical guidance meant going back to a lower dose to protect your stomach and let your system readjust. That is appropriate prescribing, but it also means you are working your way back up through doses where the appetite-suppressing effect is genuinely more modest than at maintenance. The sense that Mounjaro is not working the second time around is often, in practice, the titration phase doing exactly what it should.

Tirzepatide's weight-management effects build with dose. The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported around 20–21% average body-weight reduction at 15mg over 72 weeks, but those results accumulated across a full titration sequence, not from the starting pen. Expecting the same momentum at 2.5mg or 5mg that you experienced at a higher dose on your first course sets an unfair benchmark. The NHS's patient information for tirzepatide notes that dose increases happen in steps specifically because tolerability and response both take time to establish.

If you are mid-titration and feeling nothing, that is worth raising with your prescriber. If you are back at your previous maintenance dose and still not seeing movement, that is a different conversation altogether, and the rest of this page is for you.

The side effects have gone, but so has the appetite suppression, what that usually signals

One of the most common reasons people conclude Mounjaro is not working for them on a second course is that the nausea and queasiness from the first course do not return. Because those side effects were associated with losing weight before, their absence feels like a signal that the medicine has stopped doing its job. In reality, GI side effects and appetite suppression are separate mechanisms. The nausea is a tolerability response, most pronounced in the early weeks; the appetite reduction persists at effective doses even after nausea resolves. Your gut has simply adapted to the medicine faster on the second exposure.

What to watch instead: are you naturally eating less at mealtimes? Are you less preoccupied with food between meals? Those functional signals matter more than side-effect intensity. If your food noise is genuinely unchanged at a maintenance dose, that's a meaningful data point for a prescriber, a pattern that a page like our guide to Mounjaro not working for you personally explores in more detail. Tracking meals loosely for a couple of weeks before your next review gives your prescriber something concrete to work with, rather than a general impression.

It's also worth reviewing other medicines you've started since your first course. Some can blunt GLP-1 effects or independently promote weight gain, and a prescriber can check for interactions that weren't relevant before.

Plateau versus true non-response: how to tell the difference over time

A plateau (weight holding steady for four to eight weeks despite continuing treatment) is not the same as the medicine not working. Plateaus are a predictable feature of sustained weight loss: as body weight falls, energy expenditure adapts downward, and the calorie deficit that drove early losses narrows. This happens on Mounjaro just as it does on any other treatment, and just as it would through diet alone. The question is whether the plateau reflects a dose ceiling, a lifestyle shift, or a genuine physiological levelling-off.

A true dose ceiling usually looks like: no further appetite suppression despite being at the highest tolerated dose for eight or more weeks, combined with no weight change. That is when titrating to a higher strength (if clinically appropriate and not already at 15mg) becomes the conversation to have. If you are already at your maximum tolerated dose, a prescriber may explore whether the approach needs adjusting more broadly. There is honest guidance on this in what to consider if Mounjaro isn't working and in our overview of why Mounjaro sometimes stalls on weight loss specifically.

Understanding how long Mounjaro takes to work at each dose stage helps set realistic expectations before concluding that a second course is failing. The cost of private treatment is also worth reviewing if a longer course is needed, knowing what's included avoids surprises. A full picture of the medicine's history and evidence base is in our overview of tirzepatide's development.

If you have questions about eligibility for a restart, or want a prescriber to review whether your current dose is still appropriate, checking your eligibility with our clinical team is a good starting point. Every repeat prescription at nume is reviewed by a real prescriber before dispatch, not processed automatically.